GLP-1 coverage in Texas

Medicaid coverage of GLP-1s for obesity is optional for states under a long-standing statutory exception. Texas has exercised that discretion in a specific way.

Texas Medicaid covers weight-loss drugs but not GLP-1s.

KFF lists Texas among seven states that report covering one or more weight-loss drugs while covering no GLP-1s at all. That distinction catches people out: a weight-loss benefit in the plan documents does not mean semaglutide or tirzepatide is on the formulary. Everything below is sourced — we are not going to tell you what a Texas clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.

Why Texas is different

Texas is the largest state on KFF's list of programmes covering a weight-loss drug while covering no GLP-1, which makes it the single biggest population affected by that particular distinction. It also sits in the South, where adult obesity prevalence runs at 34.5% regionally — so the gap between what the benefit appears to offer and what it delivers affects a lot of people.

Medicaid and GLP-1s in Texas

Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where Texas sits.

If you are on Medicaid in Texas

What to do in Texas: When you call, name the drug. 'Does Texas Medicaid cover weight-loss medication' and 'does it cover semaglutide' are different questions with different answers.

Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.